These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31446299)

  • 1. Development and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma.
    Gray WA; Waldorf B; Rao MG; Stiles BL; Griffiss JM; Salata RA; Blumer JL
    J Pharm Biomed Anal; 2019 Nov; 176():112775. PubMed ID: 31446299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method.
    Kotwal P; Magotra A; Dogra A; Sharma S; Gour A; Bhatt S; Wazir P; Singh PP; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():48-55. PubMed ID: 30851617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Rifamycin Coadministration on Bedaquiline Desmethylation in Healthy Adult Volunteers.
    Healan AM; Salata RA; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Blumer JL
    Clin Pharmacol Drug Dev; 2019 May; 8(4):436-442. PubMed ID: 30500116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
    Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
    J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.
    Wallis RS; Good CE; O'Riordan MA; Blumer JL; Jacobs MR; Griffiss JM; Healan A; Salata RA
    PLoS One; 2018; 13(5):e0196756. PubMed ID: 29718967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.
    Healan AM; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Salata RA; Blumer JL
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry.
    Alffenaar JW; Bolhuis M; van Hateren K; Sturkenboom M; Akkerman O; de Lange W; Greijdanus B; van der Werf T; Touw D
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5675-80. PubMed ID: 26149993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and simultaneous determination of ten anti-tuberculosis drugs in human plasma by UPLC-MS/MS with applications in therapeutic drug monitoring.
    Wang X; Zhang H; Han Y; Huo L; Cao Y; Xu X; Ai L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122246. PubMed ID: 32668377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
    Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Validation, and Clinical Application of an Ultra-High-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for the Determination of 10 Antituberculosis Drugs in Human Serum.
    Fan X; Guo S; Zhang R; Cai Q; Lang Y; Huang J; Chen Y; Zhang Y; Xu Y; Chen M; Yang G; Cai X
    Ther Drug Monit; 2024 Aug; 46(4):477-484. PubMed ID: 38287894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and clinical use of a LC-MS/MS method for the simultaneous determination of the nine main antituberculosis drugs in human plasma.
    Fage D; Brilleman R; Deprez G; Payen MC; Cotton F
    J Pharm Biomed Anal; 2022 Jun; 215():114776. PubMed ID: 35462286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
    Perrineau S; Lachâtre M; Lê MP; Rioux C; Loubet P; Fréchet-Jachym M; Gonzales MC; Grall N; Bouvet E; Veziris N; Yazdanpanah Y; Peytavin G
    Int J Tuberc Lung Dis; 2019 Jan; 23(1):99-104. PubMed ID: 30674381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
    Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
    Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Kim HJ; Seo KA; Kim HM; Jeong ES; Ghim JL; Lee SH; Lee YM; Kim DH; Shin JG
    J Pharm Biomed Anal; 2015 Jan; 102():9-16. PubMed ID: 25218029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS.
    Winchester LC; Podany AT; Baldwin JS; Robbins BL; Fletcher CV
    J Pharm Biomed Anal; 2015 Feb; 104():55-61. PubMed ID: 25481085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis.
    Ngwalero P; Brust JCM; van Beek SW; Wasserman S; Maartens G; Meintjes G; Joubert A; Norman J; Castel S; Gandhi NR; Denti P; McIlleron H; Svensson EM; Wiesner L
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0239920. PubMed ID: 34370588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous LC-MS-MS Determination of Lopinavir and Rifabutin in Human Plasma.
    Jaiswal S; Sharma A; Shukla M; Lal J
    J Chromatogr Sci; 2017 Jul; 55(6):617-624. PubMed ID: 28334925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients in India.
    Ramachandran G; Bhavani PK; Hemanth Kumar AK; Srinivasan R; Raja K; Sudha V; Venkatesh S; Chandrasekaran C; Swaminathan S
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1564-8. PubMed ID: 24200269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions.
    van Heeswijk RP; Dannemann B; Hoetelmans RM
    J Antimicrob Chemother; 2014 Sep; 69(9):2310-8. PubMed ID: 24860154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.